Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español Drugs of Abuse & Related Topics
2006 NIDA Genetics Portfolio (Genetic Manipulation)
NIDA Genetics Programs
 
Return to Home Page
About Genetics Workgroup
Human Genetics Application Guidelines
NIDA Genetics News
NIDA Genetics Consortium
NIDA Recent Findings
NIDA Genetics Portfolio
NIDA Initiatives in Genetics
NIDA Meetings
NIDA Program Contacts
 

Resources for Genetics, Cell Biology, and Neuroscience
 
Calendar
Human Genetics
Tissue and Cell Repositories
Twin Registry
Nucleotide
Gene Expression
Genomes
Proteins
Model Organisms
Mouse
Knowledgebase for Addiction Related Genes (KARG)
Cell Biology
SfN Neuroscience Database
Gateway
Bibliographic Resources
 

Main Portfolio Index > 2006 Genetic Index > MOLECULAR PHARMA

NIDA Genetics Molecular Pharma Portfolio Listing A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
 
*
ABOOD, MARY E
Molecular Mechanisms of Cannabinoid Receptor Regulation
  5R01DA009978-10
   
ANASTASIO, NOELLE C
Role of NMDAR Regulation in Phencyclidine-Induced Neurotoxicity
  1F31DA022824-01
   
ANG, ROSALIND L
Mechanisms of hallucinogen specific neuronal response
  1F31DA020308-01A1

Back to previous page


 
*
BARI, AUSAF A Role of TrkB and TrkC in Cocaine-Induced Sensitization
  5F30DA014205-06
   
BARKER, ERIC L Psychostimulant Recognition by Serotonin Transporters
  2R01DA018682-05A2
   

BARR, GORDON A
Opiate Withdrawal & Tolerance: Development & Plasticity
  5R01DA006600-15
 
BARRES, BEN A Role of Glia in the Formation of Functional Synapses
  5R01DA015043-06
   
BENAVIDES, DAVID R MINORITY PREDOCTORAL FELLOWSHIP PROGRAM
  5F31DA020199-01NCE
   
BLONDELLE, SYLVIE E Immunogenic epitopes of rare HIV mutants as vaccines
  5R43DA021175-02

Back to previous page


 
*
CHAVKIN, CHARLES Regulation of Opioid Signaling by Tyr-Phosphorylation
  5R37DA011672-08
 
CLECK, JESSICA N The Role of Alpha Synuclein in Cocaine Mediated Behavior
  5F31DA019757-02
   
COLES, LISA D Changes in Brain and Placental Distribution During Pregnancy
  1F31DA022816-01
 


CONRAD, KELLY L Cocaine Craving and Receptor Trafficking
  1F31DA021448-01A1

Back to previous page


 
*
DAMAJ, MOHAMAD IMAD Role of calcium-dependent mechanisms in nicotine's tolerance and effects
  2R01DA012610-04A2
   
DEWEY, WILLIAM L Effects of Opiates on Cellular Mechanisms
  5K05DA000480-07
   
DIETZ, DAVID M Individual Differences in Sensitization to Amphetamine
  1F31DA019745-01A1

Back to previous page


 
*
EDWARDS, ROBERT H
Presynaptic Mechanisms of Neural Plasticity
  2P01DA010154-11A1
   
ELMER, GREGORY I
Microarray analysis of morphine's behavioral effects
  5R01DA015087-03

Back to previous page


 
*
FRIEDMAN, THEODORE C
Genes and Proteins Leading to Addiction
  5R01DA014659-05

Back to previous page


 
*
GANAPATHY, VADIVEL Molecular Analysis of a Novel Opioid Peptide Transporter
  1R21DA021560-01
   
GARNER, CRAIG C SAP97 Isoforms in Trafficking Synaptic GluR1
  5R01DA016758-04
   
GEORGE, SUSAN R RECEPTORS MEDIATING DRUG DEPENDENCE
  5R01DA007223-15
   
GOODMAN, RICHARD H. Identification of gene targets for morphine & other drugs of abuse.
  5R01DA019456-02
 
GRIMES, JILL M Adolescent Anabolic Steroids, GABA and Aggression
  5F31DA018033-03
   
GRODZICKER, TERRI I CSHL Cellular Biology of Addiction
  5R13DA019791-02

Back to previous page


 

*
HOLTZMAN, STEPHEN G Maternal Separation: Rat Model of Opioid Vulnerability
  5R01DA014122-05
   

HRUBY, VICTOR J
New Modalities for Treatment of Pain and Drug Abuse
  5P01DA006284-16
   
HRUBY, VICTOR J NOVEL NON-PEPTIDE OPIOID LIGANDS FOR PAIN
  5R01DA013449-07
   

HUBERT, GEORGE W
Anatomy and Activation of Nucleus Accumbens CART Neurons
  1F32DA021056-01A1
   
HURD, YASMIN L Dynorphin /kappa mesolimbic system in heroin abuse
  7R01DA015446-04


Back to previous page


 
*
ITZHAK, YOSSEF
Adolescent Exposure to Psychostimulants: Role of nNOS
  5R01DA019107-03

Back to previous page


 
*
JAVITCH, JONATHAN A
ARCHAEAL & BACTERIAL HOMOLOGS OF DOPAMINE TRANSPORTER
  5R01DA017293-04
   
JONES, DOUGLAS C Regulation of CART Expression in Rat Nucleus Accumbens
  5F32DA020312-02


Back to previous page


 
*
KALIVAS, PETER W Glutamate and Craving for Cocaine
  5R01DA012513-07
   
KALIVAS, PETER W
Neurobiology of Addiction Research Center (NARC)
  5P50DA015369-04
   
KELLEY, ANN E
Plasticity and learning in a corticostriatal network
  3R37DA004788-21S1
   
KELLEY, ANN E Plasticity and learning in a corticostriatal network
  5R37DA004788-21
   
KNACKSTEDT, LORI A Evaluating models of cocaine self-administration
  1F32DA021975-01
   
KO, JANE L Molecular Basis of mu-Opioid Receptor Gene Regulation
  5R01DA016673-03
   
KUHAR, MICHAEL J Mechanisms of Drugs of Abuse
  5K05DA000418-08
   
KUHAR, MICHAEL J Training Program in Neurobiology of Drug Abuse
  5T32DA015040-04

Back to previous page


 
*
LANDRY, CHARLES F Nicotine and Gene Expression in Adolescent Brain
  5R01DA019153-03
   

LAU, ELAINE K
Morphine-regulated phosphorylation of opioid receptors
  1F32DA020972-01A1
   
LAW, PING-YEE G PROTEINS AND OPIOID RECEPTOR FUNCTIONS
  5R01DA007339-16
   
LESTER, ROBIN A Subunit-specific Regulation/Neuronal Nicotinic Receptors
  5R01DA011940-07
   

LICHTMAN, ARON H
Endocannabinoid modulation of memory
  5R01DA015683-03
   
LOH, HORACE H Neurochemical Basis of Opiate Addiction
  2R01DA000564-34

Back to previous page


 

*
MADRAS, BERTHA K Cocaine-Molecular Targets/Brain Imaging and Medications
  5K05DA015305-04NCE
   

MAHATA, SUSHIL K
Chromaffin Cell physiology: Novel molecular approaches
  5R01DA011311-07
   

MATSUMOTO, RAE R
Cocaine, Sigma Receptors and Fra-2
  5R21DA017756-02
   
Mckenzie, Kathleen M Cocaine degradation: Improving antibody efficacy
  5F32DA018024-02
   
MELIKIAN, HALEY E Trafficking and Regulation of Monoamine Transporters
  5R01DA015169-05
   
Mendelson, John E. MDMA Dependence and Discontinuation Syndrome
  5R01DA017716-02
   
MERMELSTEIN, PAUL G NFAT-mediated gene expression and striatal plasticity
  5R01DA017881-02

Back to previous page


 
*
NAIR, MADHAVAN P Cocaine/Immuno and Neuropathogenesis of HIV-1 Infection
  5R01DA012366-08
   
NEISEWANDER, JANET L Limbic-cortical involvement in drug seeking
  5R01DA013649-05
 
NEUMAIER, JOHN F The Role of Serotonin Receptors In Brain Reward Circuits
  5R01DA016432-04
 
NEVE, KIM A Biological Bases of Drug Seeking Behavior
  2T32DA007262-16

Back to previous page


 
*
OSWALD, ROBERT E
Cocaine/nicotine action on acetylcholine receptors
  5R01DA011643-09

Back to previous page


 
*
PETERSON, PHILLIP K Dynorphin and Glial Cell Immunomodulation
  5R01DA009924-13
   
PICCIOTTO, MARINA R Nicotine addiction in mice lacking the neuronal nAChR
  5R01DA010455-11
 
POTTER, PHILIP M Novel Therapeutic Approaches for Narcotic Overdose
  5R01DA018116-02

Back to previous page


 
 
  No Names at this time
   

Back to previous page

 
*
RAEHAL, KIRSTEN M Opioid-Induced Somatic Effects in Betaarrestin2-KO Mice
  1F31DA021952-01
   

RAYPORT, STEPHEN G
Psychostimulant sensitization at the synaptic level
  5K02DA000356-08
   

REGGIO, PATRICIA H
Molecular Determinants for Cannabinoid Activity
  5R01DA003934-20
   
REYNOLDS, JESSICA L Mechanisms of Cocaine-Induced HIV-1 infection in NHA
  1F32DA021535-01
   
ROGGE, GEORGE A Regulation of the CART gene by promoter cis-elements
  1F31DA021970-01
   
ROTH, MICHAEL D PULMONARY EFFECTS OF HABITUAL USE OF MARIJUANA
  3R37DA003018-23S1
   
ROY, SABITA Role of Mu Opiod Receptor in Immune Function
  5K02DA015349-05
   
RUDNICK, GARY W Neurotransmitter Transport
  3R01DA008213-12S1

 
RUDNICK, GARY W Neurotransmitter Transport
  5R01DA008213-12

Back to previous page


 
*
SANDERS-BUSH, ELAINE Hallucinogens and Serotonin Signal Transduction
  5R01DA005181-17
   

SCHILTZ, CRAIG A
Molecular Basis of Addiction: Conditioning and Relapse
  5F30DA016503-04
   
SHARP, BURT M Interaction Between Nicotine and Stress
  5R01DA003977-22
 
SIGGINS, GEORGE R Morphine Like Brain Peptides-Cellular Neurobiology
  5R01DA003665-23
 

 

SIMEN, ARTHUR A Epigenetic Factors in Stress-enhanced Acquisition of Cocaine Self-Administration.
  1R03DA022251-01
   
SMITH, DESMOND J Voxelation: a new method for 3D gene expression analysis
  3R01DA015802-05S1
   
SMITH, DESMOND J Voxelation: a new method for 3D gene expression analysis
  5R01DA015802-05
   
SORKIN, ALEXANDER D Dopamine Transporter Regulation by Endocytosis
  2R01DA014204-05A1
   
STELLA, NEPHI Novel Monoacylglycerol Lipase
  1R21DA022469-01
   
STOWERS, RONALD S Genetic Dissection of Synaptic Transmission
  5K01DA019458-02
   
SURRATT, CHRISTOPHER K Dopamine Transporter Structure-Function Studies
  3R15DA016604-01S2

Back to previous page


 
*
THOMAS, DAVID L
HIV HCV Coinfection Antiviral Therapy and Fibrosis
  5R01DA013806-07
   
TOLL, LAWRENCE R
Subtype-Selective Nicotinic Receptor Ligands as Smoking Cessation Pharmacotherapy
  1R01DA020811-01
 
TURRIGIANO, GINA G
Homeostatic tuning of synapses in recurrent networks
  5R01DA016455-05
 
 
* No Names at this time.

Back to previous page


 
*
VAUGHAN, ROXANNE A
Phosphorylation and Regulation of Dopamine Transporters
  5R01DA013147-07
   
VON ZASTROW, MARK E
Mechanisms Regulating Endocytosis of Opioid Receptors
  2R01DA012864-06
 
VORTHERMS, TIMOTHY A
Salvinorin A interactions with the kappa opioid receptor
  1F32DA022188-01

Back to previous page


 
*
WALKER, BRUCE D Harvard University Center for AIDS Research
  5P30AI060354-03
   
WEINSHENKER, DAVID Mechanism of Disulfiram-Induced Cocaine Abstinence
  1R01DA017963-01A2
   
WEINSTEIN, HAREL MOLECULAR DETERMINANTS FOR THE ACTION OF HALLUCINOGENS
  5K05DA000060-26
   
WEINSTEIN, HAREL Structure and Function of Neurotransmitter Transporters
  5P01DA012408-08
 

 

WEINSTEIN, HAREL HALLUCINOGENS & 5-HT2A RECEPTORS: MECHANISMS AND EFFECTS
  3P01DA012923-05S1
   
WHISTLER, JENNIFER L G Protein Coupled Receptor Trafficking and Opiate Drugs
  5R01DA015232-04
   
WHITEAKER, PAUL Immunochemical Protocols for Nicotinic Receptors
  5R21DA019655-02
   
WINZER-SERHAN, URSULA H Nicotinic Modulation of Hippocampal Development
  5R01DA016487-03
   
WOLF, MARINA E Glutamate and psychostimulant-induced neuroadaptations
  5K02DA000453-07
   
WOLF, MARINA E Dopamine and Glutamate Receptor Interactions
  5R37DA015835-04
   
WOODS, JAMES H Development of Esterases for the Treatment of Cocaine Overdose and Abuse
  1R01DA021416-01

Back to previous page


 
* No Names at this time.

Back to previous page


 
*
YANO, MOTOYO Methylphenidate-induced gene expression in the cortex
  5F30DA017998-03

Back to previous page


 
*
ZAHNISER, NANCY R
COCAINE SENSITIZATION AND THE DOPAMINE TRANSPORTER
  5R37DA004216-18
   
ZAHNISER, NANCY R Cocaine Sensitization & Dopamine Transporter Regulation
  5K05DA015050-05

Back to previous page


 
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Return to top
 
 
 
 
Any questions or concerns regarding the genetics programs please contact Jonathan D. Pollock Ph.D. (301) 443-1887 or jp183r@nih.gov


NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment


National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Tuesday, March 11, 2008. The U.S. government's official web portal